This is a standing reference. It is revised when the position changes rather than replaced with a new article, and the briefings link back to it rather than restating it. Read it as a map of where to look, not as a substitute for the instruments themselves. Every one of them is linked below and each is the authority for its own position.
There is no single statute, and that is the whole problem
People approaching this sector for the first time look for the Act that governs it. There is not one. What there is instead is a set of frameworks written for other purposes, each of which catches part of the activity, with gaps between them that nobody designed and nobody is responsible for.
That structure explains almost everything about how the sector behaves. It explains why the same procedure can be performed lawfully by people with entirely different backgrounds. It explains why compliant operators struggle to demonstrate the difference. And it explains why every public conversation about the sector reaches for the word unregulated, which is inaccurate but not unreasonable as shorthand for a framework nobody can summarise in a sentence.
Medicines law: the framework with the most teeth
Botulinum toxin products are prescription only medicines under the Human Medicines Regulations 2012. That has three consequences that matter more than anything else in this reference.
First, supply requires a prescription from an appropriate practitioner. Second, professional standards published by the prescribing professions require the prescriber to assess the patient personally rather than prescribing remotely for cosmetic purposes. Third, advertising a prescription only medicine to the general public is prohibited, which is why naming a toxin brand in consumer marketing is a problem regardless of framing.
This is the part of the framework with real enforcement behind it, and it is the part the sector most consistently underestimates.
Medical device law: most fillers, and a common misunderstanding
Most dermal fillers are regulated as medical devices under the Medical Devices Regulations 2002 as amended, with the Medicines and Healthcare products Regulatory Agency as the regulator. Great Britain and Northern Ireland are on different footings under the Windsor Framework arrangements, which is another reason to name the jurisdiction.
Device regulation establishes that a manufacturer has followed a conformity assessment route appropriate to the device's classification for its stated intended purpose. It is not a determination that a product achieves a particular cosmetic outcome, and it is not equivalent to the marketing authorisation process a medicine goes through. Marketing that presents a conformity mark as clinical endorsement is describing the wrong thing.
Premises: four nations, four bodies, four scopes
Independent healthcare premises are registered by the Care Quality Commission in England, Healthcare Improvement Scotland in Scotland, Healthcare Inspectorate Wales in Wales, and the Regulation and Quality Improvement Authority in Northern Ireland.
Critically, the categories that trigger registration are not the same in each nation. In England, registration follows from carrying on a regulated activity as defined in the relevant regulations, and a substantial amount of purely non surgical injectable work falls outside that definition. Scotland's regime turns in part on whether the service is provided by particular categories of registered healthcare professional, which is a materially different test. Any statement about clinic registration in the UK that does not name a nation is incomplete.
Practitioners: two populations, one procedure
A registered healthcare professional performing cosmetic procedures remains bound by their regulator's standards in that work, including working within the limits of competence, holding appropriate indemnity, obtaining valid consent and maintaining confidentiality. Their regulator can act on their registration.
A practitioner with no healthcare registration performing the same procedure is, in most of the UK, subject to no equivalent framework. General law still applies to them: medicines law, consumer law, advertising rules, health and safety and the criminal law. What does not apply is a professional standard enforced by a body that can stop them practising. That asymmetry is the substance of the entire regulatory debate.
If you take one thing from this reference, take this: the question is not whether the sector is regulated. It is which of several frameworks applies to this practitioner, in this nation, for this procedure, using this product. Four variables, and changing any one of them changes the answer.
Age: an England only Act
The Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 makes it an offence in England to administer botulinum toxin or a subcutaneous, submucous or intradermal filler to a person under 18 for a cosmetic purpose, and to make arrangements or bookings for such treatment. There are narrow exceptions for treatment by or under the direction of specified registered healthcare professionals for medical purposes.
It extends to England. Describing it as a UK wide ban is one of the most frequently repeated errors in this sector, and it appears constantly in generative answers about UK aesthetics.
Licensing: a power, not a scheme
Section 180 of the Health and Care Act 2022 gives the Secretary of State a power to make regulations creating a licensing scheme for specified non surgical cosmetic procedures in England. The Department of Health and Social Care has consulted on how such a scheme might work.
A power is not a scheme, and a consultation is not a rule. Until regulations are made and commenced, there is no licence to hold and no licence to lose. Check the section's commencement position directly rather than relying on any summary, including this one.
ObservedThe power is on the face of the Act. Its commencement status is recorded on legislation.gov.uk and is the only reliable source for it.AnalysisThe delay has the shape of a scoping problem rather than a disagreement of principle. Deciding which procedures sit in which risk tier is the difficult part, and it is expensive to get wrong in either direction.Consumer, advertising and financial law: the frameworks that bind everyone
Three bodies of law apply regardless of registration status and are routinely overlooked.
The advertising rules, administered by the Advertising Standards Authority under the CAP Code, cover substantiation of objective claims, the treatment of before and after imagery, disclosure of commercial arrangements, and the responsible marketing of cosmetic interventions. Consumer protection law, including the Consumer Rights Act 2015, governs services, unfair contract terms, deposits and cancellation. Financial services regulation applies where credit is offered or arranged, and credit broking is a regulated activity requiring authorisation or an applicable exemption.
The last of those is the least understood in this sector and involves the regulator with the most enforcement capacity. A clinic introducing patients to a finance provider should be able to state in writing whether it is authorised, an appointed representative, or relying on an exemption.
How to use this reference
Start with the four variables: which nation, which practitioner, which procedure, which product. Then work through the frameworks each variable engages. Do not start from the word regulated, because it will not resolve into anything useful.
And check the instruments. Every position in this reference can change, some of them with little notice, and the linked source is always better than our summary of it.